Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

eXoZymes Inc. - Common Stock (NQ:EXOZ)

12.69 -0.12 (-0.94%)
Streaming Delayed Price Updated: 12:12 PM EDT, Jun 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,460
Open 13.54
Bid (Size) 12.35 (1)
Ask (Size) 13.39 (1)
Prev. Close 12.81
Today's Range 12.69 - 13.54
52wk Range 9.750 - 23.99
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga

Performance

YTD
-28.3%
-28.3%
1 Month
-15.6%
-15.6%
3 Month
-10.6%
-10.6%
6 Month
-28.3%
-28.3%
1 Year
-28.3%
-28.3%

More News

Read More
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
eXoZymes Highlights Scalable Biomanufacturing Platform and First Spinout, NCTx, on Grow Everything Podcast
Via ACCESS Newswire
eXoZymes Provides First Quarter 2025 and NCTx Subsidiary Update at 5PM EST Today
Via ACCESS Newswire
eXoZymes to Host First Quarter 2025 and Subsidiary NCTx Update on Monday May 12, 2025, at 5PM EST
Via ACCESS Newswire
eXoZymes Launches Subsidiary, NCTx, to Unlock a Promising Compound for Gut and Liver Health
Via ACCESS Newswire
Bringing clarity and precision to the cell-free space by introducing exozymes
From eXoZymes Inc.
Via GlobeNewswire
New to The Street's FOX Business "Late Night T.V." Special Airs Tonight – Show #650 – Featuring Health In Tech CEO Julia Qian (NASDAQ:HIT), BioVie's Dr. Joseph Palumbo (NASDAQ:BIVI), eXoZymes Co-Founder & VP of Research Tyler Korman (EXOZ), and ARRIVE AI
Via ACCESS Newswire
BioClick – an enzyme engineering game-changer, launched by eXoZymes and supported by a $300K NIH grant
From eXoZymes Inc.
Via GlobeNewswire
eXoZymes appoints experienced biomanufacturing executive, Damien Perriman, as CCO
From eXoZymes Inc.
Via GlobeNewswire
eXoZymes Provides Fourth Quarter and Full Year 2024 Update
From eXoZymes Inc.
Via GlobeNewswire
Earnings Scheduled For April 2, 2025
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
eXoZymes to Host Fourth Quarter and Full Year 2024 Results Conference Call on Wednesday April 2, 2025
From eXoZymes Inc.
Via GlobeNewswire
New to the Street Airs Show #630 on Fox Business Network Tonight at 10:30 PM PST Featuring Roadzen ($RDZN), BioVie ($BIVI), AtlasClear (ATCH), eXoZymes ($EXOZ), and EvolveHealthandLifestyle.com With Craig Bruce
Via ACCESS Newswire
eXoZymes and MDB Capital Announce Leadership Transition at eXoZymes Inc.
From eXoZymes Inc.
Via GlobeNewswire
eXoZymes Announces Nasdaq Bell Ringing to Commemorate Initial Public Offering
From eXoZymes Inc.
Via GlobeNewswire

Frequently Asked Questions

Is eXoZymes Inc. - Common Stock publicly traded?
Yes, eXoZymes Inc. - Common Stock is publicly traded.
What exchange does eXoZymes Inc. - Common Stock trade on?
eXoZymes Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for eXoZymes Inc. - Common Stock?
The ticker symbol for eXoZymes Inc. - Common Stock is EXOZ on the Nasdaq Stock Market
What is the current price of eXoZymes Inc. - Common Stock?
The current price of eXoZymes Inc. - Common Stock is 12.69
When was eXoZymes Inc. - Common Stock last traded?
The last trade of eXoZymes Inc. - Common Stock was at 06/16/25 12:12 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.